Latest filing published 23 Aug 2007 for CORCEPT THERAPEUTICS INC, €1.5M.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -33.1%Entry US$2.96 · Close at T+365 US$1.98
- +210.7%Entry US$1.21 · Close at T+365 US$3.76
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Alix Marduel: trading record in brief
Alix Marduel is a declared insider at 2 companies; the most frequent names are Corcept Therapeutics Inc and NeurogesX Inc. In total, 6 filings cover trades dated from 30 March 2007 to 25 March 2008.
Every open-market trade on record is a purchase: 5 purchases worth €5.6M, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2008 to date brings 2 purchases and no sales.
In size, the median ticket on the buying side is €1.1M.
The latest filing, published on 26 March 2008, reports an open-market purchase of €23k in Corcept Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Alix Marduel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 952,381 shares@ US$2.10Common StockSEC:0001209191-07-050098:0Canonical exit: 15 Nov 2007 (T+90)
- 1,735,673 sharesCommon StockSEC:0001181431-07-030592:0
- 1,500,000 shares@ US$1.00Common StockSEC:0001209191-07-021076:0Canonical exit: 28 Jun 2007 (T+90)
3 of 3 declarations
